189 related articles for article (PubMed ID: 23290950)
1. Serum soluble ST2 and interleukin-33 levels in patients with pulmonary arterial hypertension.
Carlomagno G; Messalli G; Melillo RM; Stanziola AA; Visciano C; Mercurio V; Imbriaco M; Ghio S; Sofia M; Bonaduce D; Fazio S
Int J Cardiol; 2013 Sep; 168(2):1545-7. PubMed ID: 23290950
[No Abstract] [Full Text] [Related]
2. NT-proBNP can be used to detect right ventricular systolic dysfunction in pulmonary hypertension.
Blyth KG; Groenning BA; Mark PB; Martin TN; Foster JE; Steedman T; Morton JJ; Dargie HJ; Peacock AJ
Eur Respir J; 2007 Apr; 29(4):737-44. PubMed ID: 17135228
[TBL] [Abstract][Full Text] [Related]
3. Novel Biomarkers of Cardiac Stress, Cardiovascular Dysfunction, and Outcomes in HIV-Infected Individuals.
Secemsky EA; Scherzer R; Nitta E; Wu AH; Lange DC; Deeks SG; Martin JN; Snider J; Ganz P; Hsue PY
JACC Heart Fail; 2015 Aug; 3(8):591-9. PubMed ID: 26164679
[TBL] [Abstract][Full Text] [Related]
4. Utility of right ventricular Tei-index for assessing disease severity and determining response to treatment in patients with pulmonary arterial hypertension.
Ogihara Y; Yamada N; Dohi K; Matsuda A; Tsuji A; Ota S; Ishikura K; Nakamura M; Ito M
J Cardiol; 2014 Feb; 63(2):149-53. PubMed ID: 24012334
[TBL] [Abstract][Full Text] [Related]
5. Treatment goals of pulmonary hypertension.
McLaughlin VV; Gaine SP; Howard LS; Leuchte HH; Mathier MA; Mehta S; Palazzini M; Park MH; Tapson VF; Sitbon O
J Am Coll Cardiol; 2013 Dec; 62(25 Suppl):D73-81. PubMed ID: 24355644
[TBL] [Abstract][Full Text] [Related]
6. Interleukin 33 and ST2 in non-ST-elevation myocardial infarction: comparison with Global Registry of Acute Coronary Events Risk Scoring and NT-proBNP.
Dhillon OS; Narayan HK; Quinn PA; Squire IB; Davies JE; Ng LL
Am Heart J; 2011 Jun; 161(6):1163-70. PubMed ID: 21641364
[TBL] [Abstract][Full Text] [Related]
7. Cystatin C: a potential biomarker for pulmonary arterial hypertension.
Fenster BE; Lasalvia L; Schroeder JD; Smyser J; Silveira LJ; Buckner JK; Brown KK
Respirology; 2014 May; 19(4):583-9. PubMed ID: 24628703
[TBL] [Abstract][Full Text] [Related]
8. Response to letter by Wang Q et al. regarding article "Serum soluble ST2 and interleukin-33 levels in patients with pulmonary arterial hypertension".
Carlomagno G; Fazio S
Int J Cardiol; 2013 Oct; 168(3):3122. PubMed ID: 23632111
[No Abstract] [Full Text] [Related]
9. QTc prolongation is associated with impaired right ventricular function and predicts mortality in pulmonary hypertension.
Rich JD; Thenappan T; Freed B; Patel AR; Thisted RA; Childers R; Archer SL
Int J Cardiol; 2013 Aug; 167(3):669-76. PubMed ID: 22459397
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of cardiac magnetic resonance imaging for idiopathic pulmonary arterial hypertension before initiating intravenous prostacyclin therapy.
Yamada Y; Okuda S; Kataoka M; Tanimoto A; Tamura Y; Abe T; Okamura T; Fukuda K; Satoh T; Kuribayashi S
Circ J; 2012; 76(7):1737-43. PubMed ID: 22498565
[TBL] [Abstract][Full Text] [Related]
11. Serum levels of the soluble IL-1 receptor family member ST2 and right ventricular dysfunction.
Agoston-Coldea L; Lupu S; Hicea S; Paradis A; Mocan T
Biomark Med; 2014; 8(1):95-106. PubMed ID: 25050435
[TBL] [Abstract][Full Text] [Related]
12. Soluble ST2 and N-terminal pro-brain natriuretic peptide combination. Useful biomarker for predicting outcome of childhoodpulmonary arterial hypertension.
Chida A; Sato H; Shintani M; Nakayama T; Kawamura Y; Furutani Y; Inai K; Saji T; Matsuoka R; Nonoyama S; Nakanishi T
Circ J; 2014; 78(2):436-42. PubMed ID: 24304538
[TBL] [Abstract][Full Text] [Related]
13. Serum levels of the interleukin-1 receptor family member ST2, cardiac structure and function, and long-term mortality in patients with acute dyspnea.
Shah RV; Chen-Tournoux AA; Picard MH; van Kimmenade RR; Januzzi JL
Circ Heart Fail; 2009 Jul; 2(4):311-9. PubMed ID: 19808354
[TBL] [Abstract][Full Text] [Related]
14. Predicting value of serum soluble ST2 and interleukin-33 for risk stratification and prognosis in patients with acute myocardial infarction.
Zhang K; Zhang XC; Mi YH; Liu J
Chin Med J (Engl); 2013; 126(19):3628-31. PubMed ID: 24112154
[TBL] [Abstract][Full Text] [Related]
15. Serum soluble ST2: a potential novel mediator in left ventricular and infarct remodeling after acute myocardial infarction.
Weir RA; Miller AM; Murphy GE; Clements S; Steedman T; Connell JM; McInnes IB; Dargie HJ; McMurray JJ
J Am Coll Cardiol; 2010 Jan; 55(3):243-50. PubMed ID: 20117403
[TBL] [Abstract][Full Text] [Related]
16. Systolic right ventricular function in children and young adults with pulmonary artery hypertension secondary to congenital heart disease and tetralogy of Fallot: tricuspid annular plane systolic excursion (TAPSE) and magnetic resonance imaging data.
Koestenberger M; Nagel B; Avian A; Ravekes W; Sorantin E; Cvirn G; Beran E; Halb V; Gamillscheg A
Congenit Heart Dis; 2012; 7(3):250-8. PubMed ID: 22494699
[TBL] [Abstract][Full Text] [Related]
17. Nuclear IL-33 regulates soluble ST2 receptor and IL-6 expression in primary human arterial endothelial cells and is decreased in idiopathic pulmonary arterial hypertension.
Shao D; Perros F; Caramori G; Meng C; Dormuller P; Chou PC; Church C; Papi A; Casolari P; Welsh D; Peacock A; Humbert M; Adcock IM; Wort SJ
Biochem Biophys Res Commun; 2014 Aug; 451(1):8-14. PubMed ID: 25003325
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-1 receptor-related protein ST2 and mitral valve repair outcome in patients with chronic degenerative mitral regurgitation.
Galeone A; Lessana A; Mascolo E; Di Serio F; Marraudino N; Laborde F; Paparella D
Thorac Cardiovasc Surg; 2014 Feb; 62(1):47-51. PubMed ID: 24065602
[TBL] [Abstract][Full Text] [Related]
19. GDF-15 and soluble ST2 as biomarkers of right ventricular dysfunction in pulmonary hypertension.
Keranov S; Widmann L; Jafari L; Liebetrau C; Keller T; Troidl C; Kriechbaum S; Voss S; Bauer P; Richter MJ; Tello K; Gall H; Ghofrani HA; Wiedenroth CB; Guth S; Seeger W; Hamm CW; Nef H; Dörr O
Biomark Med; 2022 Dec; 16(17):1193-1207. PubMed ID: 36790217
[No Abstract] [Full Text] [Related]
20. Restoration of right ventricular function in the treatment of pulmonary arterial hypertension.
Celant LR; Wessels JN; Kianzad A; Marcus JT; Meijboom LJ; Bogaard HJ; de Man FS; Vonk Noordegraaf A
Heart; 2023 Nov; 109(24):1844-1850. PubMed ID: 37527919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
